Home

Insights

Bal Pharma Ltd P/E Ratio

Bal Pharma Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.2 K

stocks traded

Image

Bal Pharma Ltd

NSE: BALPHARMA

PE

46.2

Last updated : 21 May 03:56 AM

Key Highlights

    The P/E Ratio of Bal Pharma Ltd is 46.2 as of 21 May 03:56 AM .a1#The P/E Ratio of Bal Pharma Ltd changed from 26.4 on March 2019 to 40.8 on March 2023 . This represents a CAGR of 9.10% over 5 years. a1#The Latest Trading Price of Bal Pharma Ltd is ₹ 103.79 as of 21 May 09:20 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Bal Pharma Ltd changed from ₹ 99.92 crore on March 2019 to ₹ 105.01 crore on March 2023 . This represents a CAGR of 1.00% over 5 years. a1#The Revenue of Bal Pharma Ltd changed from ₹ 70.08 crore to ₹ 81.76 crore over 7 quarters. This represents a CAGR of 9.21% a1#The EBITDA of Bal Pharma Ltd changed from ₹ 5.28 crore to ₹ 7.89 crore over 7 quarters. This represents a CAGR of 25.80% a1#The Net Profit of Bal Pharma Ltd changed from ₹ 0.28 crore to ₹ 0.85 crore over 7 quarters. This represents a CAGR of 88.62% a1#The Dividend Payout of Bal Pharma Ltd changed from 20.96 % on March 2019 to 25.6 % on March 2023 . This represents a CAGR of 4.08% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1926.4
Mar '200
Mar '2116.8
Mar '2228.5
Mar '2340.8

Fundamental Metrics

Market Cap

162 Cr

EPS

2.2

P/E Ratio (TTM) *

46.2

P/B Ratio (TTM) *

2.6

Day’s High

112.99

Day’s Low

102.91

DTE *

2.2

ROE *

5.1

52 Week High

132.2

52 Week Low

80.6

ROCE *

9.6

* All values are consolidated

* All values are consolidated

Image

Bal Pharma Ltd

NSE: BALPHARMA

PRICE

103.79

0.88(0.86%)

stock direction

Last updated : 21 May 09:20

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Bal Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value

Market Value

163

-0.3 X

Value addition

Asset Value

230

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

3 Cr

46.2 X

PE Ratio

Market Cap

₹162.64Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

3 Cr

46.2 X

PE Ratio

Market Cap

₹162.64Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Bal Pharma Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Bal Pharma Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Bal Pharma Ltd's Share Price stands at 103.79. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-21T09:20:00 is 2.23. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 103.79/ 2.23= 46.15.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Bal Pharma Ltd's stock is trading at approximately 46.15 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Bal Pharma Ltd’s PE Ratio (BSE: BALPHARMA)

    The Price-to-Earnings (PE) ratio, used to assess Bal Pharma Ltd's stock (BSE: BALPHARMA), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '19100
Mar '2046
Mar '2180
Mar '22160
Mar '23105

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2270
Sep '2275
Dec '2277
Mar '2283
Jun '2371
Sep '2393
Dec '2382

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '225
Sep '226
Dec '227
Mar '228
Jun '237
Sep '238
Dec '238

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '220
Sep '220
Dec '221
Mar '222
Jun '230
Sep '231
Dec '231

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1921
Mar '200
Mar '2116
Mar '2217
Mar '2326

* All values are a in %

About Bal Pharma Ltd

About Bal Pharma Ltd

    Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named 'SERVETUS' has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002. The commercial production of Formulation Plant in Uttarakhand started from 1st January, 2009. The Company floated Lifezen Healthcare Pvt Ltd during the year 2014-15 as its subsidiary. It ventured into heath care sector through its subsidiary i.e. Balance Clinics LLP. In 2016-17, it commenced its project on construction of an fully integrated API unit with an annual production capacity of 270 metric tonnes of assorted API products including Gliclazide, Ebastine, Amiloride HCL, Benzydamine HCL, Pregablin etc, located at Gauribidanur near Bangalore with an estimated investment of Rs 45 Crores. In 2017-18, the Company acquired 100% stake and management control of Golden Drugs Private Ltd, an Udaipur, Rajasthan involved in the manufacture of bulk drugs and intermediates costing Rs 14 Crores. It earmarked Rs. 36 Cr. for setting up of an bulk drug's manufacturing unit at Yadgir District , Karnataka in year 2022-23. It launched Sitagliptin (a DPP-4 Inhibitor) in the plain form, and as a combination with Metformin under the brand names SITABEND & SITABEND-M, respectively in 2023.

Bal Pharma Ltd News Hub

News

Bal Pharma declare Quarterly Result

Bal Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024. Po...

Read more

30 Apr 2024 12:51

News

Bal Pharma to table results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 February 202...

Read more

25 Jan 2024 17:14

News

Bal Pharma to conduct EGM

Bal Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Nov 2023 10:51

News

Bal Pharma to table results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2023...

Read more

21 Oct 2023 17:06

News

Bal Pharma to hold EGM

Bal Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

04 Sep 2023 10:22

News

Bal Pharma to convene AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

16 Aug 2023 16:58

Product Composition by Percentage (Revenue)

FAQs for PE of Bal Pharma Ltd

What is Bal Pharma Ltd current share price?

The current market price of Bal Pharma Ltd as of May 21, 2024 is ₹103.79.

What is Bal Pharma Ltd's market cap?

Bal Pharma Ltd's market capitalisation stood at ₹162 Cr as of May 21, 2024

What are Bal Pharma Ltd's total net assets?

According to Bal Pharma Ltd's most recent financial filings, the company's net assets total ₹230.3 Cr.

Is Bal Pharma Ltd making a profit or loss?

Bal Pharma Ltd's net Profit as of May 21, 2024 is close to ₹3 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199